Clinical Trials Directory

Trials / Completed

CompletedNCT04912947

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Complife Italia Srl · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy adult subjects with high baseline levels of oxidative stress.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTImmusystemDietary supplement containing: Piceid, Glycine, Glutamine, Acetylcysteine, Zinc and Vitamin B6
OTHERPlaceboMaltodextrin placebo capsule

Timeline

Start date
2020-10-30
Primary completion
2021-04-15
Completion
2021-04-30
First posted
2021-06-03
Last updated
2021-06-04

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04912947. Inclusion in this directory is not an endorsement.

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS) (NCT04912947) · Clinical Trials Directory